Abstract Number: 0171 • ACR Convergence 2026
Female hormonal exposures and the risk of incident giant cell arteritis and polymyalgia rheumatica: results from the French E3N prospective cohort study.
Background/Purpose: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are related inflammatory diseases of adults over 50, with a marked female predominance. While few risk…Abstract Number: 0560 • ACR Convergence 2026
Clinical Characteristics of Patients with Pediatric-Onset Rheumatic Disease-Associated Interstitial Lung Disease at Diagnosis: Results from a Single-center Cohort
Background/Purpose: Pediatric rheumatic disease-associated interstitial lung disease (PRD-ILD) encompasses a heterogeneous group of conditions with high morbidity yet remains profoundly understudied. We aimed to characterize…Abstract Number: 0803 • ACR Convergence 2026
Aging Arteries, Changing Care Settings: U.S. Giant Cell Arteritis Mortality, 1999-2020
Background/Purpose: Giant cell arteritis (GCA) is the most common systemic large-vessel vasculitis of older adults, associated with vision loss, vascular complications, and glucocorticoid-related morbidity. National…Abstract Number: 0833 • ACR Convergence 2026
Trends and Disparities in Mortality Due to Systemic Connective Tissue Disorders with Coexisting Sepsis in the United States: A 26-Year CDC WONDER Analysis
Background/Purpose: Systemic connective tissue disorders (SCTDs) predispose patients to a serious infection by means of immune dysregulation, organ involvement, and immunosuppressive therapy. Their coexistence with…Abstract Number: 1578 • ACR Convergence 2026
The Landscape of Incident Knee Diagnoses in Adults That May Mimic Symptomatic Osteoarthritis at An Early Structural Stage
Background/Purpose: To estimate the frequency and age-distribution of patients presenting with knee complaints being diagnosed with mimicker conditions to knee osteoarthritis (OA) as well as…Abstract Number: 1755 • ACR Convergence 2026
Infectious Mononucleosis associated with Increased Risk of Systemic Lupus Erythematosus and Rheumatoid Arthritis
Background/Purpose: Recent evidence suggests that Epstein-Barr virus (EBV) infection contributes to the development of systemic lupus erythematosus (SLE) through reprogramming of autoreactive B-cells. However, the…Abstract Number: 2137 • ACR Convergence 2026
Healthcare Resource Use and Economic Burden of ANCA-Associated Vasculitis in the United States
Background/Purpose: The ANCA-associated vasculitis (AAV) treatment landscape has evolved considerably in the past decade. We aimed to describe AAV healthcare resource use (HCRU) and economic…Abstract Number: 2448 • ACR Convergence 2026
Real-World Safety and Retention of Tofacitinib in Elderly versus Non-Elderly Patients With Rheumatoid Arthritis: A Retrospective Cohort Study in Taiwan
Background/Purpose: Tofacitinib, the first approved oral small-molecule Janus kinase inhibitor (JAKi), is widely used for treating rheumatoid arthritis (RA). This study aims to compare the…Abstract Number: 2740 • ACR Convergence 2026
Comparative Effectiveness of Anti-Diabetic Medications on the Risk of Post-Traumatic Osteoarthritis Outcomes
Background/Purpose: Post-traumatic osteoarthritis (PTOA) develops following joint injury and accounts for 12 - 20% of all osteoarthritis (OA). GLP1 agonists (GLP1a) and SGLT2 inhibitors (SGLT2i) are two diabetic medications…Abstract Number: 2768 • ACR Convergence 2026
Sociodemographic and Clinical Characteristics of Early- and Late-Onset Gout Among U.S. Adults: NHANES 2011-2018
Background/Purpose: Although the risk of gout increases with age, around 700,000 patients in the U.S. develop early-onset gout, commonly defined as first gout attack at…Abstract Number: 2927 • ACR Convergence 2026
Diabetes Risk in Rheumatoid Arthritis Has Not Improved Over the Modern Treatment Era
Background/Purpose: Higher disease activity and cytokine expression are associated with diabetes mellitus (DM) risk in RA (Baker, et al. Ann Rheum Dis 2021), though reports…Abstract Number: 0197 • ACR Convergence 2026
Development and Validation of a Claims-Based Algorithm for Relapse Detection in Granulomatosis With Polyangiitis and Microscopic Polyangiitis
Background/Purpose: Approximately 50% of patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) relapse within 5 years of diagnosis.1 Relapse contributes to organ damage…Abstract Number: 0582 • ACR Convergence 2026
Patient & Caregiver Global Score is a Predictor of Risk of JIA Flare: A Retrospective Cohort Study in the CARRA Registry
Background/Purpose: Planned tapering or stopping (i.e., deprescribing) of DMARDs in patients with JIA comes with risks of flare. However, few clinical factors reliably predict flares…Abstract Number: 0806 • ACR Convergence 2026
Cause-Specific Mortality in Incident Systemic Lupus Erythematosus: A Population-Based Cohort Study
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease associated with increased morbidity and premature mortality. Although overall survival has improved, important gaps remain…Abstract Number: 0862 • ACR Convergence 2026
Evidence on the Clinical Validity of the 2023 ACR/EULAR Antiphospholipid Syndrome Criteria in a Longitudinal Lupus Cohort
Background/Purpose: The 2006 Sydney classification criteria for Antiphospholipid syndrome (APS) have been widely used but our understanding of APS manifestations has evolved since then. The…
ACR Meeting Abstracts